• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Engaging patients for a more successful clinical trial

Engaging patients for a more successful clinical trial

November 15, 2016
CenterWatch Staff

Recruitment has always been a key element to a successful clinical trial, and in the past several years the concept of patient engagement—be­yond getting patients in the door—has grown. Historically for rare and orphan disease trials, engagement has helped recruit patients and make sure they are familiar with the treatments involved in the study, which makes them more willing to utilize the treat­ment once it has been approved.

Patient engagement is not a new concept. Different eClinical tools such as electronic patient-reported out­comes (ePRO) or interactive response technology (IRT) have been in use for some time as a way to get information directly from patients rather than fil­tered through the perspective of inves­tigators. Recently, however, patient ad­vocacy groups and other networks are getting involved in new ways, whether it be by coordinating with sponsors or providing input on protocols, par­ticularly for rare or complex diseases. Advocacy groups are expanding into more areas as well. Where they may have once been reserved for rare con­ditions, there are now many more patient advocacy groups available to provide resources and education to patients in a wide variety of diseases and conditions.

Engagement has become more advanced as it has expanded. Some sponsors are getting patients involved in study design, which connects di­rectly to patients via apps. Tradition­ally, a sponsor company would de­sign the study and set the endpoints without input from patients and with a focus on what doctors considered important. Today, it is more common for sponsors to ask patients: What is important to you in this study? Do the study objectives address your primary concerns? These strategies of early en­gagement can help sponsors provide the most clinically relevant endpoints to both the doctor and the patient, thus increasing the likelihood that a subject will seek to use the product once it is approved.

Patient engagement is key to the re­cruitment of patients for and retention of patients enrolled in clinical trials—but the question of how best to man­age new processes is still ongoing be­cause there are still some unaddressed regulatory concerns.

 

Written by Guest Writer Kristen Snipes. Snipes has over 18 years of pharmaceutical industry experience primarily as a program manager or clinical operations lead. Since joining Rho in 2007, she has been involved in leading and coordinating all operational activities for complex trials. She has managed analytical method development, formulation, IND filings (including CMC) and phase I-IV clinical trials. She is the Clinical Operations Service Lead for Rho, with responsibilities that include keeping the company current on industry trends and practices as well as supporting training and process development. www.rhoworld.com

This article was reprinted from Volume 23, Issue 11, of The CenterWatch Monthly, an industry leading publication providing hard-hitting, authoritative business and financial coverage of the clinical research space. The Action Items section features short columns  focusing on actionable or how-to advice from clinical trial professionals. To submit an Action Item, please contact editorial@centerwatch.com. Subscribe >>

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing